Journal
CANCER LETTERS
Volume 499, Issue -, Pages 265-278Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2020.11.023
Keywords
Pancreatic cancer; SETD8; Proliferation; DUSP10; STAT3
Categories
Funding
- National Natural Science Foundation [81871950, 81972250, 81972725]
- Scientific Innovation Project of Shanghai Education Committee [2019-01-07-00-07-E00057]
Ask authors/readers for more resources
In this study, it was found that SETD8 interacted with STAT3 on the DUSP10 promoter region to epigenetically silence DUSP10 expression, leading to enhanced ERK1/2 activation and unfavorable prognosis in pancreatic adenocarcinoma (PDAC). This study highlights the role of epigenetic mechanisms in modulating ERK1/2 activation and cell proliferation in PDAC.
Constitutive ERK1/2 activation has been frequently observed in pancreatic adenocarcinoma (PDAC). How ERK1/2 activation status been potentiated and maintained by epigenetic mechanisms has seldom been discussed in PDAC. In this study, we first examined the expression status of p-ERK1/2 in PDAC tissues by immunohistochemical staining and then screened possible epigenetic factors that displayed different expression status between p-ERK1/2 high and low groups by RNA profiling, and found that SETD8 displayed an increased expressional pattern in p-ERK1/2(high) patient group. Then the impact of SETD8 on the proliferation of PDAC cells were investigated on the basis of gain or loss-of-function assays. RNA sequencing assays were performed to screen potential SETD8 downstream targets that contribute to ERK1/2 activation. Mass spectrometry and transcriptional analysis, including dual-luciferase assay and chromatin immunoprecipitation assay (ChIP), were used to explore the molecular mechanisms that governing SETD8-mediated ERK1/2 activation. In vitro cell line studies and in vivo xenograft mouse model studies indicated that SETD8 promoted cell proliferation and increased tumor formation capacity of PDAC cell lines. Mechanism explorations uncovered that SETD8 suppressed the expression of DUSP10, which was responsible for dephosphorylation of ERK1/2. Mass spectrometry and transcriptional analysis results demonstrated that STAT3 interacted with SETD8 and recruited SETD8 to the promoter region of DUSP10, leading to epigenetic silencing of DUSP10 and the resultant activation of ERK1/2. In conclusion, SETD8 interacts with STAT3 on DUSP10 promoter region and epigenetically silences DUSP10 expression. Decreased DUSP10 expression in PDAC potentiates activation of ERK1/2 phosphorylation, resulting in unfavorable prognosis of PDAC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available